1. Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening
   Zhongyuan Luo et al, 2021, Bioorganic & Medicinal Chemistry Letters CrossRef
2. Targeting Energy Metabolism in Cancer Treatment
   Joanna Kubik et al, 2022, International Journal of Molecular Sciences CrossRef
3. Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
   Wenxiu Jiang et al, 2023, Frontiers in Genetics CrossRef
4. Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia
   Peng Ke et al, 2023, Frontiers in Oncology CrossRef
5. Glutamine Modulates Expression and Function of Glucose 6-Phosphate Dehydrogenase via NRF2 in Colon Cancer Cells
   Ibrahim H. Polat et al, 2021, Antioxidants CrossRef
6. Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival
   Pei Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
7. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes
   László Bányai et al, 2021, eLife CrossRef
8. Caffeine Targets G6PDH to Disrupt Redox Homeostasis and Inhibit Renal Cell Carcinoma Proliferation
   Huanhuan Xu et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
9. One-Pot Analytical Pipeline for Efficient and Sensitive Proteomic Analysis of Extracellular Vesicles
   Yi-Kai Liu et al, 2023, Journal of Proteome Research CrossRef
10. The Multiple Roles of Glucose-6-Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance
    Jiaqi Song et al, 2022, Life CrossRef
11. Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin
    Guanghou Fu et al, 2022, Cells CrossRef
12. Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer
    Chenxi Wang et al, 2023, Expert Opinion on Therapeutic Targets CrossRef
13. G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension
    Rongzhen Ding et al, 2024, Aging CrossRef
14. The Role of the Pentose Phosphate Pathway in Diabetes and Cancer
    Tongxin Ge et al, 2020, Frontiers in Endocrinology CrossRef
15. SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism
    Yong Wang et al, 2021, Frontiers in Oncology CrossRef
16. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
    Qinjunjie Chen et al, 2020, Frontiers in Oncology CrossRef
17. Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model
    Dongdong Tang et al, 2022, Frontiers in Genetics CrossRef
18. The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway
    Valentin Jacquier et al, 2022, International Journal of Molecular Sciences CrossRef
19. PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
    Fangfang Bi et al, 2021, Frontiers in Oncology CrossRef
20. Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
    Tao Zeng et al, 2023, Frontiers in Oncology CrossRef
21. Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications
    Qiuyang Gu et al, 2024, Aging and disease CrossRef